151 related articles for article (PubMed ID: 29623155)
1. Emergency Medicine Pharmacist Impact on Door-to-Needle Time in Patients With Acute Ischemic Stroke.
Jacoby JS; Draper HM; Dumkow LE; Farooq MU; DeYoung GR; Brandt KL
Neurohospitalist; 2018 Apr; 8(2):60-65. PubMed ID: 29623155
[TBL] [Abstract][Full Text] [Related]
2. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
Barbour J; Hushen P; Newman GC; Vidal J
Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
[TBL] [Abstract][Full Text] [Related]
3. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
4. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
Sauser K; Levine DA; Nickles AV; Reeves MJ
JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
[TBL] [Abstract][Full Text] [Related]
5. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
[TBL] [Abstract][Full Text] [Related]
6. Improved door-to-needle times and neurologic outcomes when IV tissue plasminogen activator is administered by emergency physicians with advanced neuroscience training.
Greenberg K; Maxwell CR; Moore KD; D'Ambrosio M; Liebman K; Veznedaroglu E; Sanfillippo G; Diaz C; Binning MJ
Am J Emerg Med; 2015 Feb; 33(2):234-7. PubMed ID: 25498530
[TBL] [Abstract][Full Text] [Related]
7. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
8. Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention.
Xian Y; Xu H; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Hernandez AF; Peterson ED; Schwamm LH; Fonarow GC
Stroke; 2022 Apr; 53(4):1328-1338. PubMed ID: 34802250
[TBL] [Abstract][Full Text] [Related]
9. Stop Stroke: A Brief Report on Door-to-Needle Times and Performance After Implementing an Acute Care Coordination Medical Application and Implications to Emergency Medical Services.
Dickson R; Nedelcut A; Nedelcut MM
Prehosp Disaster Med; 2017 Jun; 32(3):343-347. PubMed ID: 28219452
[TBL] [Abstract][Full Text] [Related]
10. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
[TBL] [Abstract][Full Text] [Related]
11. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
Moran JL; Nakagawa K; Asai SM; Koenig MA
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator.
Rech MA; Bennett S; Donahey E
Ann Pharmacother; 2017 Dec; 51(12):1084-1089. PubMed ID: 28759998
[TBL] [Abstract][Full Text] [Related]
13. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
[TBL] [Abstract][Full Text] [Related]
14. Impact of emergency room meetings on improvement of door-to-needle times in acute ischemic stroke patients: A single center's experience.
Acar BA
North Clin Istanb; 2018; 5(4):282-287. PubMed ID: 30859157
[TBL] [Abstract][Full Text] [Related]
15. Emergency Care of Patients with Acute Ischemic Stroke in the Kaiser Permanente Southern California Integrated Health System.
Sauser-Zachrison K; Shen E; Ajani Z; Neil WP; Sangha N; Gould MK; Sharp AL
Perm J; 2016; 20(2):10-3. PubMed ID: 27043833
[TBL] [Abstract][Full Text] [Related]
16. Reducing Door-to-Needle Time for Tissue Plasminogen Activator Administration in a Community Hospital: An Operations Study.
Pitre T; Evans K; Tang X; Shamsuddin A; Mir A; Lee C; Zia Z; Costa AP; Giilck S
Qual Manag Health Care; 2020; 29(4):188-193. PubMed ID: 32991535
[TBL] [Abstract][Full Text] [Related]
17. Older Stroke Patients with High Stroke Scores Have Delayed Door-To-Needle Times.
Birnbaum LA; Rodriguez JS; Topel CH; Behrouz R; Misra V; Palacio S; Patterson MG; Motz DS; Goros MW; Cornell JE; Caron JR
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2668-2672. PubMed ID: 27476342
[TBL] [Abstract][Full Text] [Related]
18. Impact of emergency department arrival time on door-to-needle time in patients with acute stroke.
Ganti L; Mirajkar A; Banerjee P; Stead T; Hanna A; Tsau J; Khan M; Garg A
Front Neurol; 2023; 14():1126472. PubMed ID: 37064176
[TBL] [Abstract][Full Text] [Related]
19. How a CT-Direct Protocol at an American Comprehensive Stroke Center Led to Door-to-Needle Times Less Than 30 Minutes.
Caputo LM; Jensen J; Whaley M; Kozlowski MJ; Fanale CV; Wagner JC; Orlando A; Bar-Or D
Neurohospitalist; 2017 Apr; 7(2):70-73. PubMed ID: 28400899
[TBL] [Abstract][Full Text] [Related]
20. Improving door-to-needle times: a single center validation of the target stroke hypothesis.
Ruff IM; Ali SF; Goldstein JN; Lev M; Copen WA; McIntyre J; Rost NS; Schwamm LH
Stroke; 2014 Feb; 45(2):504-8. PubMed ID: 24399372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
